Publications by authors named "Mark Markowski"

Claim this Profile
N
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.
David J Einstein, Melissa L Abel, Jeanny B Aragon-Ching, Philip M Arlen, Karen A Autio, Mark C Markowski

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital Pathology-based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer.
Mark C Markowski, Yi Ren, Meghan Tierney, Trevor J Royce, Rikiya Yamashita

Eur Urol Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic Neuroendocrine Tumor incidentally found on 68Ga-PSMA PET/CT.
Rodrigo Luna, Daniel A Laheru, Eun Ji Shin, Chen Lossos, Mahalia T Robinson, Mark C Markowski

Nuklearmedizin· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inferred clonal hematopoiesis from tumor DNA sequencing among men with prostate cancer: correlation with somatic tumor alterations and outcomes.
Yasaman Iranmanesh, Noha Omar, Arya Rasouli, Alex Baras, Sergiu Pasca, Mark C Markowski

Oncologist· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of SGLT2 Inhibitor Initiation and PSA Response in Prostate Cancer.
Etan R Aber, Michael A Carducci, Channing J Paller, Sam R Denmeade, Kelli Rourke, Mark C Markowski

Prostate· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bipolar androgen therapy for treatment of metastatic castration-resistant prostate cancer: A case series.
Elizabeth U Tran, Eric Royz, Kyra Yamamoto, Samantha Marley, Alexander Song, Mark Markowski

Prostate· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial Experience with [Lu]Lu-PSMA-617 After Regulatory Approval for Metastatic Castration-Resistant Prostate Cancer: Efficacy, Safety, and Outcome Prediction.
Andrei Gafita, Andrew Voter, Somya Shesadri, Avery Spitz, Catherine H Marshall, Mark C Markowski

J Nucl Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib Without Androgen Deprivation for High-Risk Biochemically Recurrent Prostate Cancer Following Prostatectomy: A Nonrandomized Controlled Trial.
Catherine H Marshall, Benjamin A Teply, Jiayun Lu, Lia Oliveira, Hao Wang, Mark C Markowski

JAMA Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRIUMPH: phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive prostate cancer harboring germline homologous recombination repair gene mutations.
Mark C Markowski, Cora N Sternberg, Hao Wang, Tingchang Wang, Laura Linville

Oncologist· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of PSMA-targeted radiotheranostics in an experimental model of renal cell carcinoma.
Rajan Singh, Anand K Thotakura, Suresh Alati, Alla Lisok, Zirui Jiang, Mark C Markowski

Front Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial.
Channing J Paller, Marianna L Zahurak, Adel Mandl, Nicole A Metri, Aliya Lalji, Mark C Markowski

Cancer Res Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer.
Catherine H Marshall, Lukasz P Gondek, Violet Daniels, Changxue Lu, Sergiu Pasca, Mark C Markowski

Prostate· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial.
Mark C Markowski, Mary-Ellen Taplin, Rahul Aggarwal, Laura A Sena, Hao Wang

Nat Commun· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression.
Jiayu Chen, Qizhi Zheng, Jessica L Hicks, Levent Trabzonlu, Busra Ozbek, Mark C Markowski

JCI Insight· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Prostate Cancer Molecular Subtype With Deep Learning on Histopathologic Images.
Eric Erak, Lia DePaula Oliveira, Adrianna A Mendes, Oluwademilade Dairo, Onur Ertunc, Mark Markowski

Mod Pathol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Test-retest repeatability of organ uptake on PSMA-targeted F-DCFPyL PET/CT in patients with prostate cancer.
Rudolf A Werner, Susanne Lütje, Bilêl Habacha, Lena Bundschuh, Takahiro Higuchi, Mark C Markowski

Prostate· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular Expression of Prostate-specific Membrane Antigen (PSMA) in MiTF Family Translocation Renal Cell Carcinoma and Related Neoplasms.
Ezra G Baraban, Yasser Ged, Nirmish Singla, Mohammad E Allaf, Michael A Gorin, Mark C Markowski

Appl Immunohistochem Mol Morphol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and clinical efficacy of immune checkpoint inhibition and stereotactic body radiotherapy in patients with spine metastasis.
Emerson Lee, Xuguang Chen, Michael C LeCompte, Lawrence R Kleinberg, Russell K Hales, Mark C Markowski

J Neurosurg Spine· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer.
Samuel R Denmeade, Laura A Sena, Hao Wang, Emmanuel S Antonarakis, Mark C Markowski

Oncologist· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of repeatability of radiomic features derived from PET scans: Results from a F-DCFPyL test-retest cohort.
Rudolf A Werner, Bilêl Habacha, Susanne Lütje, Lena Bundschuh, Alekandser Kosmala, Mark C Markowski

Prostate· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-timepoint imaging with PSMA-targeted [F]F-Florastamin PET/CT: lesion detection and comparison to conventional imaging.
Sara Sheikhbahaei, Ricardo Bello Martinez, Mark C Markowski, Mario A Eisenberger, Kenneth J Pienta

Ann Nucl Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated analyses for RESTORE cohort C: A trial of bipolar androgen therapy for patients with newly castration-resistant prostate cancer.
Laura A Sena, Tingchang Wang, Hao Wang, Mark C Markowski, Emmanuel S Antonarakis

Eur J Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of bromodomain and extraterminal (BET) proteins in prostate cancer.
Adel Mandl, Mark C Markowski, Michael A Carducci, Emmanuel S Antonarakis

Expert Opin Investig Drugs· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression.
Jiayu Chen, Qizhi Zheng, Jessica L Hicks, Levent Trabzonlu, Busra Ozbek, Mark C Markowski

bioRxiv· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial.
Phuoc T Tran, Kathryn Lowe, Hua-Ling Tsai, Daniel Y Song, Arthur Y Hung, Mark Markowski

J Clin Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis